Patricia A. Turney's most recent trade in Arcutis Biotherapeutics Inc was a trade of 831 Common Stock done at an average price of $15.3 . Disclosure was reported to the exchange on March 6, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics Inc | Patricia A. Turney | SVP, Operations | Sale of securities on an exchange or to another person at price $ 15.26 per share. | 06 Mar 2023 | 831 | 62,862 (0%) | 0% | 15.3 | 12,684 | Common Stock |
| Arcutis Biotherapeutics Inc | Patricia A. Turney | SVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 47,600 | 47,600 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Patricia A. Turney | SVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 18,000 | 63,693 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Patricia A. Turney | SVP, Operations | Sale of securities on an exchange or to another person at price $ 15.82 per share. | 28 Feb 2023 | 1,414 | 45,711 (0%) | 0% | 15.8 | 22,367 | Common Stock |
| Arcutis Biotherapeutics Inc | Patricia A. Turney | SVP, Operations | Sale of securities on an exchange or to another person at price $ 16.17 per share. | 28 Feb 2023 | 936 | 47,125 (0%) | 0% | 16.2 | 15,132 | Common Stock |
| Arcutis Biotherapeutics Inc | Patricia A. Turney | SVP, Operations | Sale of securities on an exchange or to another person at price $ 16.50 per share. | 28 Feb 2023 | 18 | 45,693 (0%) | 0% | 16.5 | 297 | Common Stock |
| Arcutis Biotherapeutics Inc | Patricia A. Turney | SVP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2022 | 25,328 | 134,615 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Patricia A. Turney | SVP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.52 per share. | 23 Mar 2022 | 25,328 | 56,441 (0%) | 0% | 6.5 | 165,139 | Common Stock |
| Arcutis Biotherapeutics Inc | Patricia A. Turney | SVP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2022 | 15,331 | 144,612 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Patricia A. Turney | SVP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.52 per share. | 23 Mar 2022 | 15,331 | 46,444 (0%) | 0% | 6.5 | 99,958 | Common Stock |
| Arcutis Biotherapeutics Inc | Patricia A. Turney | SVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 35,300 | 35,300 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Patricia A. Turney | SVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 13,300 | 32,136 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Patricia A. Turney | SVP, Operations | Sale of securities on an exchange or to another person at price $ 16.86 per share. | 03 Mar 2022 | 993 | 31,143 (0%) | 0% | 16.9 | 16,741 | Common Stock |
| Arcutis Biotherapeutics Inc | Patricia A. Turney | SVP, Operations | Sale of securities on an exchange or to another person at price $ 16.43 per share. | 03 Mar 2022 | 30 | 31,113 (0%) | 0% | 16.4 | 493 | Common Stock |
| Arcutis Biotherapeutics Inc | Patricia A. Turney | SVP, Operations | Sale of securities on an exchange or to another person at price $ 17.75 per share. | 01 Mar 2022 | 936 | 18,836 (0%) | 0% | 17.8 | 16,617 | Common Stock |
| Arcutis Biotherapeutics Inc | Patricia A. Turney | SVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 28,800 | 28,800 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Patricia A. Turney | SVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 9,500 | 18,771 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Patricia A. Turney | SVP, Operations | Sale of securities on an exchange or to another person at price $ 34.52 per share. | 01 Mar 2021 | 934 | 9,271 (0%) | 0% | 34.5 | 32,242 | Common Stock |